REG - BlackRock Group Willis Towers Watson - Form 8.3 - Willis Towers Watson Plc

Willis Towers WatsonAnnouncement

10/06/2021 15:25

RNS Number : 5180B
  
BlackRock Group
  
10 June 2021
  
 

Ap19
FORM 8.3
 
IRISH TAKEOVER PANEL
 
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
 
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
 
1.       KEY INFORMATION
 




Name of person dealing (Note 1)


BlackRock, Inc.




Company dealt in


Willis Towers Watson plc




Class of relevant security to which the dealings being disclosed relate (Note 2)


US$0.000304635 ordinary shares




Date of dealing


09 June 2021




 
2.         INTERESTS AND SHORT POSITIONS
(a)        Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)




 


Long


Short




 


Number


 


(%)


Number


 


(%)




(1) Relevant securities


8,795,376 (6.81%)


6,082 (0.00%)




(2) Derivatives (other than options)


2,336,874 (1.81%)


53,293 (0.04%)




(3) Options and agreements to purchase/sell


0 (0.00%)


0 (0.00%)




Total


11,132,250 (8.63%)


59,375 (0.04%)



 
 
 
 
 
 
 



 
(b)        Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)




Class of relevant security:


Long


Short




 


Number


 


(%)


Number


 


(%)




(1) Relevant securities


 


 




 
(2) Derivatives (other than options)


 


 




 
(3) Options and agreements to purchase/sell


 


 




Total


 


 



 
 
 
 
 
 
 




 

Ap20
 
 
1.       DEALINGS (Note 4)
 
(a)      Purchases and sales
 
 




 
Purchase/sale


 
Number of relevant securities


 
Price per unit (Note 5)




Purchase


143


USD 254.1731




Purchase


25


USD 254.2120




Purchase


170


USD 254.4135




Purchase


1,228


USD 254.5100




Sale


25


USD 254.2104




Sale


60


USD 254.3000




Sale


1,400


USD 254.3268




Sale


11,048


USD 254.5100




    
Please note: there was also a Transfer In of 1,106 Shares
(b)      Derivatives transactions (other than options transactions)
 




Product name,
e.g. CFD


Nature of transaction
(Note 6)


Number of relevant securities
(Note 7)


Price per unit
(Note 5)




 


 


 


 




    
(c)      Options transactions in respect of existing relevant securities
 
 
(i)       Writing, selling, purchasing or varying
 




Product name,
e.g. call option


Writing, selling, purchasing, varying etc.


Number of securities to which the option relates (Note 7)


Exercise price


Type, e.g. American, European etc.


Expiry date


Option money paid/received per unit (Note 5)




 


 


 


 


 


 


 




 
(ii)      Exercising
 




Product name,
e.g. call option


Number of securities


Exercise price per unit (Note 5)




 


 


 




 
(d)      Other dealings (including transactions in respect of new securities) (Note 4)
 




Nature of transaction
(Note 8)


Details


Price per unit
(if applicable) (Note 5)




 


 


 




    

 

Ap21
 
2.       OTHER INFORMATION
 
Agreements, arrangements or understandings relating to options or derivatives
 
 
Full details of any agreement, arrangement or understanding between the person disclosing and any other 

person relating to the voting rights of any relevant securities under any option referred to on this form or relating 
to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred 
to on this form is referenced. If none, this should be stated.
 
 
 
None
 
 
 
Is a Supplemental Form 8 attached? (Note 9)                                    NO
 




Date of disclosure


10 June 2021




Contact name


Jana Blumenstein




Telephone number


+44 20 7743 3650




If a connected EFM, name of offeree/offeror with which connected


 




If a connected EFM, state nature of connection (Note 10)


 




 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
ISEFMMBTMTMBBIB